Wedbush initiated coverage of Healthcare Realty Trust with an Outperform rating and $17 price target. The analyst started coverage of the U.S. real estate investment trust industry with an initial universe of 30 stocks and seven sectors. The firm says the U.S. REITs could reverse 2,200 basis points of underperformance since 2022 that has “created very attractive stock valuations.” However, valuation alone is not typically an effective investment thesis, usually requiring incremental catalysts before playing a role, the analyst tells investors in a research note. Wedbush believes REIT balance sheets and platforms place the industry at the top of the commercial real estate food chain. It rates 13 of the 30 stocks Outperform with zero Underperform ratings for now.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on HR:
- Seeking up to 8% Dividend Yield? Wedbush Suggests 2 Dividend Stocks to Buy
- UPDATE – Healthcare Realty Trust Releases Fifth Corporate Responsibility Report and 2023 GRESB Assessment Ranking
- Healthcare Realty Trust Releases Fifth Corporate Responsibility Report and 2023 GRESB Assessment Ranking
- Ex-Dividend Date Nearing for These 10 Stocks – Week of August 14 – August 18, 2023
- Healthcare Realty Trust price target lowered to $24 from $25 at Barclays